Sunbelt Securities’s 10x Genomics TXG Stock Holding History

Sunbelt Securities’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.23K	Hold	152	–	–	﹤0.01%	1799
2025 Q4	$2.48K	Hold	152	–	–	﹤0.01%	1829
2025 Q3	$1.78K	Buy	+152	New	+$1.98K	﹤0.01%	1904

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sunbelt Securities's TXG Position: Q1 2026 in Review

Sunbelt Securities held its 10x Genomics (TXG) position steady in Q1 2026 at 152 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Sunbelt Securities first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 331 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Sunbelt Securities held 152 shares of 10x Genomics worth $3.23K as of Q1 2026.
Sunbelt Securities left its 10x Genomics share count unchanged in Q1 2026.
10x Genomics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1799 holding.
Sunbelt Securities first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
331 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.